Global Lung Cancer Academy Experts

Dr Corey Langer is a professor of medicine at the University of Pennsylvania, Perelman School of Medicine, where he serves as clinical director of thoracic oncology in the Abramson Cancer Center. He received his medical degree from Boston University and completed his residency in medicine at the Graduate Hospital, University of Pennsylvania, and his hematology/oncology fellowship at Presbyterian University of Pennsylvania and Fox Chase Cancer Center.

At the University of Pennsylvania, Dr Langer leads clinical research efforts in thoracic malignancy as part of the Interdisciplinary Thoracic Oncology Program and conducts research focused on the role of targeted therapy and immunotherapy in non-small cell lung cancer (NSCLC). He also co-directs the Thoracic Translational Center of Excellence, where he concentrates on the clinical end of bench-to-bedside projects. For the past 34 years, since completing his fellowship, Dr Langer has led or co-led over 140 clinical trials in both SCLC and NSCLC, as well as mesothelioma and head and neck cancer.

Dr Langer is co-chair of the Medical Oncology Committee for NRG Cooperative Oncology Group and serves on the core thoracic committees of both NRG and the Eastern Cooperative Oncology Group. He is a fellow of the American College of Physicians and a member of the American Society of Clinical Oncology, American Association for Cancer Research, and International Association for the Study of Lung Cancer (IASLC). Since 2016, he has served as editor-in-chief of the IASLC Lung Cancer News.

Prof Solange Peters is a full professor, chair of medical oncology, and chair of thoracic malignancies in the Department of Oncology, University Hospital of Lausanne, Switzerland. She received both her medical degree and PhD from the University Hospital of Lausanne. After completing her clinical education in medical oncology and molecular biology in Switzerland and Italy, Prof Peters specialized in thoracic tumors, lung cancer, and pleural tumors.

Prof Peters is currently in charge of teaching and patient care in thoracic malignancies at Lausanne University, where she is building a translational program in collaboration with the Swiss Federal Institute of Technology and the Ludwig Institute. Her main fields of interest are new biomarkers discovery and validation in preclinical and clinical settings, multimodality strategies for locally advanced non-small cell lung cancer, and cancer immunotherapy. Her current research projects mainly focus on innovative immunotherapy combinations and new immunomodulating treatments across thoracic malignancies. She acts as the local principal investigator (PI) for lung trials opened at Lausanne Cancer Centre and is co-PI of several other trials. Additionally, she acts as scientific coordinator and Foundation Council member of the European Thoracic Oncology Platform.

Prof Peters has authored numerous peer-reviewed manuscripts and book chapters, acts as associate editor of the Annals of Oncology, serves on the editorial board of several other oncology journals, and was the deputy editor of the Journal of Thoracic Oncology for 10 years. Prof Peters is active in the educational programs of the European Society for Medical Oncology, where she created the Women for Oncology Committee and for which she is the youngest president ever, serving from 2020–2022, and the International Association for the Study of Lung Cancer, where she was a previous member of the board of directors.

Dr Carlos H. Barrios is director of the Oncology Research Center at Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil. He is adjunct assistant professor of the William Harrington Latin American Program of the University of Miami School of Medicine, FL, and physician member of the Oncoclínicas Group.

Dr Barrios received his medical degree from PUCRS. He is board certified in internal medicine, having trained at the Hospital de Clínicas, Federal University of Rio Grande do Sul, Porto Alegre, and Jackson Memorial Hospital, University of Miami. He is also board certified in hematology and oncology, having trained at Barnes-Jewish Hospital, Washington University, St Louis, MO.

Dr Barrios is a member of the Executive Board of the Breast International Group and is very interested in clinical research, participating in over 250 industry-sponsored and academic clinical trials over the last 20 years. He has many abstract presentations in national and international congresses and has contributed significantly to the literature with numerous peer-reviewed publications. He has a strong interest in the development of international research collaborations and implementation of cooperative research infrastructures in Latin America. He is cofounder and current director of the Latin American Cooperative Oncology Group, which congregates more than 100 investigators in more than 70 institutions from 14 different countries in Latin America.